AMGN vs IBOC · P/E 24, rev $10.05B vs P/E 11, rev $435.0M
Amgen Inc (AMGN) versus International Bancshares Corporation (IBOC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
International Bancshares Corporation (IBOC) is a banks - regional company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported IBOC revenue for 2026-06-30 was $435.0M. Net income was $198.0M. IBOC currently screens at market cap $4.35B and trailing P/E 10.7.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. IBOC currently screens at market cap $4.35B and trailing P/E 10.7.
Not investment advice. Open the AMGN and IBOC stock pages for the full models.
Not investment advice.